- Kids’ ER Visits for Injuries Rose During Lockdown, While Non-Injury Cases Fell
- Estrogen Taken During Gender-Affirming Surgeries Won’t Raise Blood Clot Risk: Study
- During Lockdowns, Women Took on Most of Burden of Child Care
- As More Legal Pot Dispensaries Open, More Young Adults Start Using
- Vision Problems? Here’s a Guide to Which Specialist Is Right for You
- Biden Outlines ‘Bold’ National Vaccine Effort
- COVID Pandemic Shortened U.S. Life Expectancy by More Than a Year
- Should Your Child Get a COVID Test?
- AHA News: What Heart and Stroke Patients Should Know About COVID-19 Vaccines
- New Hope Against Diseases Marked by Progressive Scarring of Lung Tissue
Clinical Trials Update: Sept. 10, 2010
Here are the latest clinical trials, courtesy of ClinicalConnection.com:
Psoriasis
This study of moderate-to-severe plaque psoriasis will compare an investigational combination of two FDA-approved drugs with a single approved psoriasis medication.
The research site is in Denver, Colo.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/psoriasis.aspx.
—–
Insomnia
To qualify for this study, candidates must be aged 21 to 64, have trouble staying asleep, and be in general good health.
The research site is in New York City.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/insomnia.aspx.
—–
Hot Flashes
This 12-week study will evaluate the safety and effectiveness of the study drug in eliminating hot flashes in post-menopausal women. Participants must be 40 or older and have 50 to 60 hot flashes per week.
The research site is in Sacramento, Calif.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/hot_flashes.aspx.
—–
Copyright 2010 ClinicalConnection.com. All rights reserved.
Source: HealthDay
